10.1136/bmj.39489.470347.AD [DOI] [PMC free article] [PubMed] [Google Scholar] 43.Sepandar F, Daneshpazhooh M, Djalali M, Mohammadi H, Yaghubi E, Fakhri Z, et al
fda.gov Teichman SL, et al
But once I saw the relative dearth of treatment options and have become essentially fluent, or as fluent as one can be without being an academic researcher or a neurologist in the research on, you know, these, these pharmacologic interventions, to me, it became very clear that if this was a condition that we were going to halt the, um, the, the growing prevalence of we were going to need to
Peptide Therapeutics: Current Status and Future Directions. Drug Discovery Today , 20(1), 122-128, 2015